|
1) Müller-Hermelink HK, Montserrat E, Catovsky D, et al. Chronic lymphocytic leukaemia/small lymphocytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 180-2
|
|
|
|
|
2) Harris NL, Nathwani BN, Swerdlow SH, et al. Follicular lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 220-6
|
|
|
|
|
|
3) Swerdlow SH, Campo E, Seto M, et al. Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al. editos. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 229-32
|
|
|
|
|
|
4) Campo E, Pileri SA, Jaffe ES, et al. Nodal marginal zone lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 218-9
|
|
|
|
|
|
5) Nathwani BN, Jaffe ES, Swerdlow SH. EBV positive diffuse large B-cell lymphoma of the elderly. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 243-4
|
|
|
|
|
|
6) Willemze R, Swerdlow SH, Harris NL, et al. Primary cutaneous follicle centre lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 227-8
|
|
|
|
|
|
7) Meijer CJLM, Vergier B, Duncan LM, et al. Primary cutaneous DLBCL, leg type. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC. 2008. p. 242
|
|
|
|
|
|
8) Piris M, Foucar K, Mollejo M, et al. Splenic B-cell lymphoma/leukaemia, unclassifiable. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 191-3
|
|
|
|
|
|
9) Quintanilla-Martinez L, Kimura H, Jaffe ES. EBV-positive T-cell lymphoproliferative disorders of childhood. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 278-80
|
|
|
|
|
|
10) Kluin PM, Raphael M, Harris NL, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 265-6
|
|
|
|
|
|
11) Jaffe ES, Stein H, Swerdlow SH, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 267-8
|
|
|
|
|
|
12) Chan JKC, Aozasa K, Gaulard P. DLBCL associated with chronic inflammation. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 245-6
|
|
|
|
|
|
13) Facchetti F, Jones DM, Petrella T. Blastic plasmacytoid dendritic cell neoplasm. In: Swerdlow SH, Campo E, Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IRAC; 2008. p. 145-7
|
|
|
|
|
|
14) Sehn LH, Berry B, Chhanabhai M, et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2007; 109: 1857-61
|
|
|
|